Phibro Animal Health (PAHC) Debt to Equity (2013 - 2026)

Phibro Animal Health's Debt to Equity history runs 14 years deep, the most recent figure standing at $0.38 for Q1 2026.

• In Q1 2026, Debt to Equity fell 84.05% year-over-year to $0.38; the TTM figure through Mar 2026 stood at $0.38 (down 84.05% YoY), while the FY2025 annual figure was $0.36, down 54.93% from the prior year.
• Debt to Equity was $0.38 for Q1 2026 at Phibro Animal Health, down from $1.88 in the prior quarter.
• In the past five years, Debt to Equity ranged from a high of $2.59 in Q4 2024 to a low of $0.36 in Q2 2025.
• Historically, Debt to Equity has averaged $1.12 across 5 years, with a median of $0.8 in 2024.
• The sharpest annual moves came in 2024 and 2026: Debt to Equity jumped 296.11% in 2024, then slumped 84.05% in 2026.
• A 5-year view of Debt to Equity shows it stood at $1.09 in 2022, then slumped by 39.96% to $0.65 in 2023, then surged by 296.11% to $2.59 in 2024, then declined by 27.47% to $1.88 in 2025, then tumbled by 79.72% to $0.38 in 2026.
• The last three Debt to Equity figures came in at $0.38 (Q1 2026), $1.88 (Q4 2025), and $2.01 (Q3 2025), per Business Quant data.